United States · FDA National Drug Code directory

Losartan Potassium and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2572_367a96b9-9983-4c67-acea-7ab1f44ea7f3
Product NDC
71335-2572
Form
TABLET, FILM COATED
Composition / generic term
losartan potassium and hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20180215
Source listing expiry
20261231

Source-listed ingredients

  • LOSARTAN POTASSIUM — 100 mg/1
  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (71335-2572-1) · 71335-2572-1
  • 90 TABLET, FILM COATED in 1 BOTTLE (71335-2572-2) · 71335-2572-2
  • 120 TABLET, FILM COATED in 1 BOTTLE (71335-2572-3) · 71335-2572-3
  • 100 TABLET, FILM COATED in 1 BOTTLE (71335-2572-4) · 71335-2572-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →